CNBC's "Fast Money"

U.S. Banking Boom…And Record Stock Run for Kymera Therapeutics 7/7/26

43 min · 7 jul 2026
aflevering U.S. Banking Boom…And Record Stock Run for Kymera Therapeutics 7/7/26 artwork

Beschrijving

Financials surging as investors countdown to second quarter bank earnings next week, expecting major growth. The traders break down what the results could mean for these names and whether banks will see major gains. Then, shares of Kymera Therapeutics soaring as its Eczema drug trial timeline moves faster than expected. The firm’s founder, president and CEO Nello Mainolfi talks trial data and where the company is heading next. Plus, SpaceX stock plummeting despite bull calls on the Street, the media market under pressure, and Coke hitting all-time highs back to its century-old IPO. Fast Money Disclaimer [https://www.cnbc.com/fast-money-disclaimer/] Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com [https://pcm.adswizz.com] for information about our collection and use of personal data for advertising.

Reacties

0

Wees de eerste die een reactie plaatst

Meld je nu aan en word lid van de CNBC's "Fast Money" community!

Probeer gratis

Probeer 14 dagen gratis

€ 9,99 / maand na proefperiode. · Elk moment opzegbaar.

  • Podcasts die je alleen op Podimo hoort
  • 20 uur luisterboeken / maand
  • Gratis podcasts

Alle afleveringen

300 afleveringen

aflevering SK Hynix Debuts on the Nasdaq… And Looking Ahead to Big Bank Earnings Results 7/10/26 artwork

SK Hynix Debuts on the Nasdaq… And Looking Ahead to Big Bank Earnings Results 7/10/26

SK Hynix begins trading on the Nasdaq in the second largest U.S. listing ever, raising over $26 billion and closing 13% above opening price. Tech strategist and analyst Dan Ives breaks down where the South Korean tech giant is heading next and what the IPO means for the memory market. Then, big banks heading into another strong earnings season next week. The traders lay out why Wall Street is expecting good results, and whether the results are sustainable long-term. Plus, Apple trading near record highs, Delta shares slipping despite its earnings report soaring above expectations, and Meta’s best week since 2024.   Fast Money Disclaimer [https://www.cnbc.com/fast-money-disclaimer/] Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com [https://pcm.adswizz.com] for information about our collection and use of personal data for advertising.

Gisteren43 min
aflevering Counting Down to SK Hynix Offering… And A Major Warning Sign in the Market 7/9/26 artwork

Counting Down to SK Hynix Offering… And A Major Warning Sign in the Market 7/9/26

Investors eyeing the AI trade this week anticipating the biggest U.S. listing by a foreign company ever. The traders break down what to expect when SK Hynix joins the Nasdaq tomorrow, and why U.S. shares could trade at a permanent premium. Then, Yen vs. Dollar hitting 40-year lows this month waving major red flags for the market. BK Asset Management managing director of FX strategy Kathy Lien lays out the dangers of Japan and U.S. rate differences and what policies could arise from Yen weakness. Plus, shares of PepsiCo falling after mixed second-quarter results, existing home prices at all-time highs, and how the World Cup is causing a spending spike across major cities.   Fast Money Disclaimer [https://www.cnbc.com/fast-money-disclaimer/] Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com [https://pcm.adswizz.com] for information about our collection and use of personal data for advertising.

9 jul 202643 min
aflevering Oil Surges After U.S. Iran Strike… And Fed Minutes Results 7/8/26 artwork

Oil Surges After U.S. Iran Strike… And Fed Minutes Results 7/8/26

Oil prices skyrocketing after President Trump strikes Iran overnight and announces the U.S.-Iran ceasefire is effectively over. Where the war is heading, and whether investors can expect oil to keep climbing. Then, the latest out of the Fed as the open market committee’s minutes report comes out. Head of investment strategy at Bryn Mawr Trust Andrew Davis gives his take on the new Fed communication framework, and why he’s expecting financials and health care to outperform come earnings season next week. Plus, Nvidia falling behind, Apple taking a $30 billion bite out of Broadcom, and the latest read on Auto sales. Fast Money Disclaimer [https://www.cnbc.com/fast-money-disclaimer/] Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com [https://pcm.adswizz.com] for information about our collection and use of personal data for advertising.

8 jul 202643 min
aflevering U.S. Banking Boom…And Record Stock Run for Kymera Therapeutics 7/7/26 artwork

U.S. Banking Boom…And Record Stock Run for Kymera Therapeutics 7/7/26

Financials surging as investors countdown to second quarter bank earnings next week, expecting major growth. The traders break down what the results could mean for these names and whether banks will see major gains. Then, shares of Kymera Therapeutics soaring as its Eczema drug trial timeline moves faster than expected. The firm’s founder, president and CEO Nello Mainolfi talks trial data and where the company is heading next. Plus, SpaceX stock plummeting despite bull calls on the Street, the media market under pressure, and Coke hitting all-time highs back to its century-old IPO. Fast Money Disclaimer [https://www.cnbc.com/fast-money-disclaimer/] Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com [https://pcm.adswizz.com] for information about our collection and use of personal data for advertising.

7 jul 202643 min